Skip to main content

ARCH Venture Partners — Portfolio, Page 9

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

236
Companies
$31.9B
Total invested
$143.1M
Avg. check
32
Industries
Biotechnology 18Health Care 16Therapeutics 9Life Science 4Medical 3Genetics 3+26 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 193216 of 236
hC Bioscience
November 2022

HC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.

Biotechnology · Cambridge$16.0M Series A
Excision BioTherapeutics
September 2022

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Biotechnology · Philadelphia$6.8M Grant
Mindstrong Health
September 2022

Mindstrong is a virtual mental health platform.

Health Care · Menlo Park$250K Grant
Codiak Biosciences
September 2022

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.

Biotechnology · San Francisco$20.0M Post Ipo Equity
Happy Health
August 2022

Happy Health is a mission-driven technology company

Health Care · Austin$60.0M Series A
Pheast Therapeutics
April 2022

Pheast Therapeutics develops checkpoint therapies to harness the innate immune system.

Biotechnology · Palo Alto$76.0M Series A
Proof Diagnostics
April 2022

Proof Diagnostics is a health technology company that develops a diagnostic test for the detection of coronavirus disease infection.

Apps · Cambridge$45.0M Series A
Jaguar Gene Therapy
March 2022

Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.

Biotechnology · Lake ForestSeries Unknown
Feelmore Labs
March 2022

Feelmore Labs is an innovative health & wellness technology company.

Fitness · Brooklyn$4.0M Debt Financing
Twist Bioscience
February 2022

Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.

B2B · San Francisco$250.0M Post Ipo Equity
Transcenta
November 2021

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.

Biopharma · HuangpuPost Ipo Equity
908 Devices
November 2021

908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.

Battery · Boston$101.0M Post Ipo Equity
Singleron Biotechnologies
November 2021

Singleron Biotechnologies is an innovative molecular diagnostic company.

Biotechnology · Nanjing$100.0M Series B
AgBiome
September 2021

AgBiome discovers and develops innovative biological and trait products for crop protection.

Agriculture · Raleigh$116.0M Series D
Altos Labs
September 2021

Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.

Biopharma · San Francisco$3.0B Series A
ImmuneID
June 2021

ImmuneID is a precision immunology company that provides a technological platform to deliver insights into the human immune response.

Biotechnology · Boston$50.0M Series A
LunaPBC
May 2021

LunaPBC is a healthcare company that transforms health data into health breakthroughs.

Biotechnology · San Diego$3.8M Series Unknown
Brii Biosciences
March 2021

Brii Biosciences is a biotechnology company that commits to bring innovative medicines to China as a way to improve public health.

Biotechnology · Beijing$155.0M Series C
Voxel8
March 2021

Voxel8 offers digital manufacturing technology designed for footwear and apparel.

3D Printing · SomervilleDebt Financing
Encoded Therapeutics
March 2021

Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.

Biotechnology · South San FranciscoSeries D
Vividion Therapeutics
February 2021

Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.

Biotechnology · San Diego$135.0M Series C
Locanabio
December 2020

Locana develops RNA-targeting gene therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.

Biotechnology · San Diego$100.0M Series B
SAGE Therapeutics
November 2020

SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.

Biotechnology · Cambridge$650.0M Post Ipo Equity
Homology Medicines
November 2020

Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.

Alternative Medicine · Lexington$60.0M Post Ipo Equity

Where ARCH Venture Partners invests

Biotechnology18
Health Care16
Therapeutics9
Life Science4
Medical3
Genetics3

About ARCH Venture Partners's portfolio

How many companies has ARCH Venture Partners invested in?

ARCH Venture Partners has invested in 236 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does ARCH Venture Partners invest in?

ARCH Venture Partners's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Medical. The firm invests across 32 different industry categories.

What is ARCH Venture Partners's largest investment?

Among tracked funding rounds, Altos Labs received $3.0B in a Series A round. ARCH Venture Partners's total known invested capital is $31.9B.

What is the average investment size for ARCH Venture Partners?

ARCH Venture Partners's average investment size is $143.1M across its portfolio of 236 companies.

What are ARCH Venture Partners's most recent investments?

Recent ARCH Venture Partners portfolio additions include hC Bioscience, Excision BioTherapeutics, Mindstrong Health, Codiak Biosciences, Happy Health. These companies were founded in 2020 or later.

Reach the founders behind these 236 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →